Electrophysiologic changes after intravitreal ranibizumab injection for the treatment of choroidal neovascular membrane (CNVM)

Patama Bhurayanontachai, Mansing Ratanasukon, Pichai JirarattanasopaRetina Unit, Department of Ophthalmology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, ThailandPurpose: To determine the pattern of electroretinographic change after an intravitreal ranibizumab (Lucentis&...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Bhurayanontachai P, Ratanasukon M, Jirarattanasopa P
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2011
Materias:
Acceso en línea:https://doaj.org/article/60f85c34c60b486f80df8414407c1411
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:60f85c34c60b486f80df8414407c1411
record_format dspace
spelling oai:doaj.org-article:60f85c34c60b486f80df8414407c14112021-12-02T04:12:00ZElectrophysiologic changes after intravitreal ranibizumab injection for the treatment of choroidal neovascular membrane (CNVM)1177-54671177-5483https://doaj.org/article/60f85c34c60b486f80df8414407c14112011-05-01T00:00:00Zhttp://www.dovepress.com/electrophysiologic-changes-after-intravitreal-ranibizumab-injection-fo-a7361https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Patama Bhurayanontachai, Mansing Ratanasukon, Pichai JirarattanasopaRetina Unit, Department of Ophthalmology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, ThailandPurpose: To determine the pattern of electroretinographic change after an intravitreal ranibizumab (Lucentis®) injection for the treatment of choroidal neovascular membrane (CNVM).Patients and methods: A prospective interventional case series of patients treated by intravitreal ranibizumab injection. Best corrected visual acuity, optical coherence tomography (OCT), and multifocal electroretinography (mfERG) were assessed prior to treatment, and 2 weeks, 1 and 3 months after treatment. Primary outcome was the functional change in amplitude and implicit time by mfERG and secondary outcome was the structural change in macular thickness by optical coherence tomography (OCT).Results: Twenty-six eyes from 25 consecutive patients were enrolled. At 3 months after treatment, the mean visual acuity (VA) improved from 1.06 to 0.84 logMAR (P = 0.034) and the mean macular thickness decreased from 389.7 to 264.4 microns (P = 0.003). The mean implicit time of the central zone showed an improvement at 3 months after treatment when compared with the response at baseline (P = 0.024) and at 1 month (P = 0.013) but the mean amplitude showed no significant change. In subgroup analysis, the eyes with initial visual acuity (VA) ≥ 20/200 had a significant improvement in mean implicit time of the peripheral zone at 2 weeks after treatment (P = 0.028). The OCT revealed a significant decrease (P < 0.003) in macular thickness at 1 and 3 months postoperatively.Conclusion: The mean implicit time of the central zone improved significantly at 3 months after treatment, whereas the mean amplitude showed no significant change. The macular thickness decreased significantly after the treatment, while VA improved to a lesser extent.Keywords: choroidal neovascular membrane (CNVM), intravitreal injection, multifocal electroretinography (mfERG), optical coherence tomography (OCT), ranibizumabBhurayanontachai PRatanasukon MJirarattanasopa PDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2011, Iss default, Pp 567-572 (2011)
institution DOAJ
collection DOAJ
language EN
topic Ophthalmology
RE1-994
spellingShingle Ophthalmology
RE1-994
Bhurayanontachai P
Ratanasukon M
Jirarattanasopa P
Electrophysiologic changes after intravitreal ranibizumab injection for the treatment of choroidal neovascular membrane (CNVM)
description Patama Bhurayanontachai, Mansing Ratanasukon, Pichai JirarattanasopaRetina Unit, Department of Ophthalmology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, ThailandPurpose: To determine the pattern of electroretinographic change after an intravitreal ranibizumab (Lucentis®) injection for the treatment of choroidal neovascular membrane (CNVM).Patients and methods: A prospective interventional case series of patients treated by intravitreal ranibizumab injection. Best corrected visual acuity, optical coherence tomography (OCT), and multifocal electroretinography (mfERG) were assessed prior to treatment, and 2 weeks, 1 and 3 months after treatment. Primary outcome was the functional change in amplitude and implicit time by mfERG and secondary outcome was the structural change in macular thickness by optical coherence tomography (OCT).Results: Twenty-six eyes from 25 consecutive patients were enrolled. At 3 months after treatment, the mean visual acuity (VA) improved from 1.06 to 0.84 logMAR (P = 0.034) and the mean macular thickness decreased from 389.7 to 264.4 microns (P = 0.003). The mean implicit time of the central zone showed an improvement at 3 months after treatment when compared with the response at baseline (P = 0.024) and at 1 month (P = 0.013) but the mean amplitude showed no significant change. In subgroup analysis, the eyes with initial visual acuity (VA) ≥ 20/200 had a significant improvement in mean implicit time of the peripheral zone at 2 weeks after treatment (P = 0.028). The OCT revealed a significant decrease (P < 0.003) in macular thickness at 1 and 3 months postoperatively.Conclusion: The mean implicit time of the central zone improved significantly at 3 months after treatment, whereas the mean amplitude showed no significant change. The macular thickness decreased significantly after the treatment, while VA improved to a lesser extent.Keywords: choroidal neovascular membrane (CNVM), intravitreal injection, multifocal electroretinography (mfERG), optical coherence tomography (OCT), ranibizumab
format article
author Bhurayanontachai P
Ratanasukon M
Jirarattanasopa P
author_facet Bhurayanontachai P
Ratanasukon M
Jirarattanasopa P
author_sort Bhurayanontachai P
title Electrophysiologic changes after intravitreal ranibizumab injection for the treatment of choroidal neovascular membrane (CNVM)
title_short Electrophysiologic changes after intravitreal ranibizumab injection for the treatment of choroidal neovascular membrane (CNVM)
title_full Electrophysiologic changes after intravitreal ranibizumab injection for the treatment of choroidal neovascular membrane (CNVM)
title_fullStr Electrophysiologic changes after intravitreal ranibizumab injection for the treatment of choroidal neovascular membrane (CNVM)
title_full_unstemmed Electrophysiologic changes after intravitreal ranibizumab injection for the treatment of choroidal neovascular membrane (CNVM)
title_sort electrophysiologic changes after intravitreal ranibizumab injection for the treatment of choroidal neovascular membrane (cnvm)
publisher Dove Medical Press
publishDate 2011
url https://doaj.org/article/60f85c34c60b486f80df8414407c1411
work_keys_str_mv AT bhurayanontachaip electrophysiologicchangesafterintravitrealranibizumabinjectionforthetreatmentofchoroidalneovascularmembranecnvm
AT ratanasukonm electrophysiologicchangesafterintravitrealranibizumabinjectionforthetreatmentofchoroidalneovascularmembranecnvm
AT jirarattanasopap electrophysiologicchangesafterintravitrealranibizumabinjectionforthetreatmentofchoroidalneovascularmembranecnvm
_version_ 1718401371967848448